
Keywords
- Hepatitis B, Hepatitis C, Cameroon, Yaounde, Prevalence, Risk factors
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Abstract
Introduction: Hepatitis B (HBV) and C (HCV) virus infections represent a major public health problem, with significant mortality and morbidity worldwide. The aim of this study was to determine the prevalence of HBsAg and anti-HCV antibodies, and to investigate the risk factors associated with these two infections.
Patients and methods: An analytical cross-sectional study was carried out during a free screening campaign for viral hepatitis B and C organized by the University Teaching Hospital of Yaounde from 20th to 23rd August 2019. Screening for HBsAg and anti-HCV antibodies was carried out using a rapid diagnostic test (On Site HBsAg/HCV Ab Rapid Test (CTK Inc 10110 Mesa Rim Road San Diego, CA 92121 USA) in accordance with the manufacturer’s Instruction. Positive samples had a confirmatory ELISA test. A structured questionnaire was used to investigate the risk factors for viral hepatitis B and C.
Results: A total of 746 participants (412 women, 334 men) were registered. The average age of the participants was 29.6 ± 15.5 years. The prevalence of HBsAg was 10.3% (men: 14.7%; women: 7%; p = 0.002). The prevalence of HCV-Ab was 4.7% (men: 6.3%; women: 3.4%; p = 0.08). Unprotected sexual intercourse (59.4%), dental care (38.7%) and scarification (37.1%) were the main factors of HBV and HCV transmission. Male sex (OR = 2.2; IC = 1.3 – 3.6; p = 0.002), lack of vaccination (OR = 3.4; IC = 1.2 – 9.6; p = 0.01), tattoos (OR = 6.6; IC = 1.4 – 30.2; p = 0.02) and close contact with an HBV-infected person (OR = 1.7; IC = 1.01 – 2.9; p = 0.04) were the factors associated with HBV transmission. Age groups ? 55 years (OR = 1.3; IC = 1.1 – 1.5; p < 0.0001) and [45 – 54] (OR = 1.06; IC = 1.0 – 1.1; p = 0.03) unprotected sexual intercourse (OR = 3.5; IC = 1.4 – 8.7; p = 0.003), dental care (OR = 2.3; IC = 1.1 – 4.5; p = 0.02) were associated with HCV infection.
Conclusion: The prevalences of HBsAg and HCV-Ab are high in this population. Unprotected sexual intercourse, dental care and scarification were the most common risk factors.
References
- World Health Organization, World Health Organization, Global Hepatitis Programme. Global hepatitis report, 2017 [Internet]. 2017 [cité 28 févr 2019]. Disponible sur: http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1
- Waheed Y, Siddiq M, Jamil Z, Najmi MH. Hepatitis elimination by 2030: Progress and challenges. World J Gastroenterol. 28 nov 2018;24(44):4959?61.
- Bigna JJ, Amougou MA, Asangbeh SL, Kenne AM, Noumegni SRN, Ngo-Malabo ET, et al. Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis. BMJ Open. juin 2017;7(6):e015298.
- Ankouane F, Noah Noah D, Atangana MM, Kamgaing Simo R, Guekam PR, Biwolé Sida M. Séroprévalence des virus des hépatites B et C, du VIH-1/2 et de la syphilis chez les donneurs de sang de l’hôpital central de Yaoundé, région du centre, Cameroun. Transfus Clin Biol. mai 2016;23(2):72?7.
- Groc S, Abbate JL, Le Gal F, Gerber A, Tuaillon E, Albert J-L, et al. High prevalence and diversity of hepatitis B and hepatitis delta virus in Gabon. J Viral Hepat. janv 2019;26(1):170?82.
- Sbai A, Baha W, Ougabrai H, Allalia T, Dersi N, Lazaar F, et al. Prévalence de l’infection par le virus de l’hépatite B et l’évaluation des facteurs de risque au Maroc. Pathol Biol. oct 2012;60(5):e65?9.
- Mbaawuaga EM, Iroegbu CU, Ike AC. Hepatitis B Virus (HBV) Serological Patterns in Benue State, Nigeria. Open J Med Microbiol. 2014;4(1):1?10.
- Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R. The status of hepatitis B control in the African region. Pan Afr Med J [Internet]. 2017 [cité 11 oct 2019];27. Disponible sur: http://www.panafrican-med-journal.com/content/series/27/3/17/full/
- Bhate P, Saraf N, Parikh P, Ingle M, Phadke A, Sawant P. CROSS SECTIONAL STUDY OF PREVALENCE AND RISK FACTORS OF HEPATITIS B AND HEPATITIS C INFECTION IN A RURAL VILLAGE OF INDIA. Arq Gastroenterol. déc 2015;52(4):321?4.
- Ashraf H, Alam NH, Rothermundt C, Brooks A, Bardhan P, Hossain L, et al. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infect Dis [Internet]. déc 2010 [cité 28 sept 2019];10(1). Disponible sur: https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-10-208
- Bigna JJ, Amougou MA, Asangbeh SL, Kenne AM, Nansseu JR. Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis. BMJ Open. août 2017;7(8):e015748.
- Njouom R, Siffert I, Texier G, Lachenal G, Tejiokem MC, Pépin J, et al. The burden of hepatitis C virus in Cameroon: Spatial epidemiology and historical perspective. J Viral Hepat. août 2018;25(8):959?68.
- Kowo MP, Andoulo FA, Ngek LT, Sizimboue DT, Ndam AN, Ondo BE, et al. Prevalence of Hepatitis C Virus and Associated Risk Factors among Inmates at New Bell Prison, Douala, Cameroon. Open J Epidemiol. 2019;9(2):119?28.
- Baha W, Foullous A, Dersi N, They-they TP, alaoui KE, Nourichafi N, et al. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health [Internet]. déc 2013 [cité 28 sept 2019];13(1). Disponible sur: http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-50
- Elzouki A-N, Smeo M-N, Sammud M, Elahmer O, Daw M, Furarah A, et al. Prevalence of hepatitis B and C virus infections and their related risk factors in Libya: a national seroepidemiological survey. East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit. juill 2013;19(7):589?99.
- Kandeel A, Genedy M, El-Refai S, Funk AL, Fontanet A, Talaat M. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment. Liver Int. janv 2017;37(1):45?53.
- Groc S, Abbate JL, Le Gal F, Gerber A, Tuaillon E, Albert J-L, et al. High prevalence and diversity of hepatitis B and hepatitis delta virus in Gabon. J Viral Hepat. janv 2019;26(1):170?82.
- Nadeem M, Sattar Z, Mohammad Khan S, Ahsan I, Naheed R, Mehmood Khattak T, et al. Identification of risk factors for hepatitis B and C in Peshawar, Pakistan. HIVAIDS – Res Palliat Care. août 2015;223.
- Mauss, Berg, Rockstroch. Hepatology A clinicl textbook 9th Edition 2018.
- Ankouane F, Noah Noah D, Atangana MM, Simo RK, Guekam PR, Biwole-Sida M. Séroprévalence des virus des hépatites B et C, du VIH-1/2 et de la syphilis chez les donneurs de sang de l’hôpital central de Yaoundé, région du centre, Cameroun. /data/revues/12467820/unassign/S1246782015004383/. 2015;
- Ageely H, Mahfouz MS, Gaffar A, Elmakki E, Elhassan I, Yasin AO, et al. Prevalence and Risk Factors of Hepatitis B Virus in Jazan Region, Saudi Arabia: Cross-Sectional Health Facility Based Study. Health (N Y). 2015;7(4):459?65.
- Ali N, Hussain W, Hayat A, Shah T, Wen R, Zeb I, et al. Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients: a multicentric study. Eur J Gastroenterol Hepatol. janv 2019;31(1):29?33.